blafarm.....very cohesive and trenchant observation......very last paragraph I believe encapsulates the genesis of what you are saying..."if Vyera pricing precludes partnering..why are they talking to potentially 11 Pharma companies?...answer might be that there are some exclusionary provisions in their initial agreement.
I can't imagine with Nader's long term view of the potential, that he would be so short sighted as to pigeon hole himself on exclusive partnering and licensing with any one entity, unless he didn't care because of long view possible B.O.